Abstract
Allogeneic Hematopoietic Cell Transplantation in Patients ≤ 60 Years with Intermediate-Risk Acute Myeloid Leukemia in First Remission - Results of the Randomized Etal-1 Trial-
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have